Human medicines European public assessment report (EPAR): Hyftor, sirolimus, Angiofibroma;Tuberous Sclerosis, Date of authorisation: 15/05/2023, Revision: 2, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 25 September 2023 - 13:07

Human medicines European public assessment report (EPAR): Hyftor, sirolimus, Angiofibroma;Tuberous Sclerosis, Date of authorisation: 15/05/2023, Revision: 2, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/hyftor

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters